Inflow

Market position

Inflow operates in the digital ADHD care market alongside companies addressing diagnosis, coaching, telehealth and medication management, including Done, Cerebral, Brili, Tiimo and Elemy, and within the broader growth of self-therapy applications. Co-founder Seb Isaacs has positioned the company as taking a more holistic approach spanning the full ADHD care journey.

The company positions itself as covering all aspects of the ADHD care journey rather than a single element such as diagnosis, coaching or medication, combining CBT-based self-help content with clinician- and coach-led community support and, following the Lina Health acquisition, telehealth. It also emphasizes peer-reviewed research on the app and involvement of a clinical psychologist co-founder.

Technology

A mobile self-help application delivering CBT-based content, psychoeducation, daily exercises and challenges around habit formation, ADHD-focused mindfulness techniques, and community features. The company has pursued clinical validation: co-founder Dr. George Sachs and colleagues published a peer-reviewed feasibility and usability study of the app in August 2022, and the company said it planned a broader randomized controlled trial to assess efficacy. Preliminary open-study testing was reported to show decreases in members' ADHD symptoms and impairment.

Go-to-market

Direct-to-consumer distribution of the app with a free seven-day trial converting to paid subscription, supplemented by clinician- and coach-led community programming. The company said proceeds from its Series A would fund product development and headcount growth.

Adults living with ADHD who are seeking self-management tools; the company frames its offering as an option for people facing long waits and cost barriers in accessing behavioral health clinicians. ADHD is described as affecting as much as 10% of the global population, with one estimate placing U.S. prevalence at 3.5%.

Geography

Headquartered in London, United Kingdom, with a consumer app offering; investor base spans the UK and the United States.

History

The company was founded in 2020 in London and took part in Y Combinator's Summer 2021 batch. In January 2022 it announced a $2.3 million seed round led by Hoxton Ventures. In August 2022 the founding team published a peer-reviewed feasibility and usability study of the app, and in November 2022 Inflow acquired Lina Health to move into telehealth. In January 2023 the company announced an $11 million Series A led by Octopus Ventures, bringing total funding raised since founding to $14 million, with Octopus health tech partner Will Gibbs joining the board. Y Combinator's company directory subsequently listed Inflow's status as acquired.

Risks & controversies

Reporting notes that companies treating ADHD via telehealth and medication management have faced increased scrutiny in recent years, as loosened federal prescribing regulations in the U.S. drove membership growth; virtual pharmacy TruePill, a partner to several telehealth companies, faced Drug Enforcement Administration action against its license over controlled-substance prescriptions. Inflow's efficacy evidence at the time of its Series A was limited to a feasibility and usability study and preliminary open-study results, with a randomized controlled trial still planned.